Adderall vs Vyvanse: ADHD Stimulant Comparison

Q: Can you switch from Adderall to Vyvanse?

Yes — switching between Adderall and Vyvanse is common and generally straightforward, but it must be done under prescriber supervision. Because Vyvanse is a prodrug with a different onset and duration profile, the transition is typically a direct switch rather than a taper. Your prescriber will determine an appropriate starting strength for Vyvanse based on your current response to Adderall. Do not attempt to convert or estimate equivalences yourself.

Head-to-Head · ADHD Stimulants · DEA Schedule II

Adderall / Adderall XR

Adderall

amphetamine / dextroamphetamine
mixed amphetamine salts

Vyvanse

lisdexamfetamine dimesylate
prodrug → dextroamphetamine

Both Adderall and Vyvanse are Schedule II amphetamine-based stimulants used for ADHD, but they work differently. Adderall delivers amphetamine directly. Vyvanse is a prodrug that your body must convert — a design that changes its onset, duration, abuse potential, and approved uses. Here is how they compare across every meaningful dimension.

The core difference: Adderall is a blend of amphetamine salts that are active immediately on absorption. Vyvanse is lisdexamfetamine — an amphetamine molecule bonded to the amino acid lysine. That bond must be cleaved by enzymes in red blood cells before any active drug is released. The conversion is gradual, which is why Vyvanse has a slower onset, a smoother effect profile, and is harder to misuse via non-oral routes.

DEA Schedule II Rx only — cannot be called in by phone Both require 30-day supplies Generics available for both

Side-by-side comparison

Adderall vs Vyvanse at a Glance

Scroll horizontally on small screens. Duration figures are approximate; individual variation is significant.

Dimension	Adderall / Adderall XR	Vyvanse
Generic name	Amphetamine / dextroamphetamine (mixed amphetamine salts)	Lisdexamfetamine dimesylate
Drug class	CNS stimulant — amphetamine	CNS stimulant — amphetamine prodrug
DEA schedule	Schedule II	Schedule II
Mechanism	Mixed amphetamine salts — approximately 75% dextroamphetamine, 25% levoamphetamine. Releases norepinephrine and dopamine from nerve terminals; blocks reuptake.	Prodrug converted to dextroamphetamine by enzymes in red blood cells. Inactive until converted — onset is slower but effect is more sustained.
FDA-approved uses	ADHD (ages 3+); narcolepsy	ADHD (ages 6+); moderate-to-severe binge eating disorder (adults)
Formulations	Immediate-release (IR) tablets; extended-release (XR) capsules	Capsules (contents can be dissolved in water); chewable tablets
Duration of effect	IR: ~4–6 hours XR: ~8–10 hours	~10–14 hours
Onset	Faster — active amphetamine salts are absorbed directly	Slower — requires enzymatic conversion after absorption
Comedown	IR formulation can produce a noticeable "crash" as it wears off; XR softer	Generally smoother — gradual conversion means gradual offset
Abuse potential	Higher — active salts can be crushed and misused via non-oral routes	Lower (by design) — prodrug is inactive if snorted or injected; conversion only occurs after ingestion
Available strengths	IR: 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg, 30mg XR: 5mg, 10mg, 15mg, 20mg, 25mg, 30mg	20mg, 30mg, 40mg, 50mg, 60mg, 70mg
Generic available?	Yes — generics widely available for both IR and XR	Yes — brand exclusivity ended 2023; generics now available
Typical cost	Generic IR/XR significantly lower cost; widely covered by insurance	Generic Vyvanse now available at lower cost than brand; still typically more expensive than Adderall generics
FDA black box warning	Both carry a black box warning: high potential for abuse and dependence. Misuse of amphetamines may cause sudden death and serious cardiovascular adverse events.

Both medications require a prescription and cannot be refilled without a new written prescription. Dosing decisions are made by your prescriber based on your individual clinical situation.

Individual drug profiles

Each Drug in Depth

The colored stripe encodes the drug's identity throughout this page. Orange = Adderall; Blue = Vyvanse.

Adderall Adderall · Adderall XR

Duration 4–10 hrs

ADHD ages 3+ Narcolepsy IR + XR forms

Adderall has been on the market since 1996 and is among the most studied medications for ADHD. It is a mixture of four amphetamine salts — roughly 75% dextroamphetamine salts and 25% levoamphetamine salts. Both isomers are pharmacologically active, but dextroamphetamine has a stronger CNS effect while levoamphetamine contributes more to peripheral (cardiovascular) effects.

The immediate-release formulation acts quickly and wears off within hours, which allows for flexible scheduling — some people prefer it for targeted coverage during specific parts of the day, or use a second dose in the afternoon. The extended-release capsule delivers a biphasic release that roughly mimics taking two doses hours apart.

Because Adderall's amphetamine salts are immediately active on absorption, they carry a higher abuse potential than Vyvanse. The drug can be misused by crushing tablets or capsule contents and administering via non-oral routes, producing a faster, more intense effect. This is the primary clinical reason some prescribers prefer Vyvanse when abuse risk is a concern.

Controlled substance note

Adderall is Schedule II. Prescriptions cannot be called in — a new written prescription is required each month. Sharing, selling, or using without a prescription is a federal crime and carries serious cardiovascular and psychiatric risks.

Vyvanse Vyvanse · lisdexamfetamine

Duration 10–14 hrs

ADHD ages 6+ Binge Eating Disorder Prodrug

Vyvanse (lisdexamfetamine) was approved by the FDA in 2007, designed from the outset with abuse deterrence as a structural feature rather than an add-on. The active drug — dextroamphetamine — is covalently bonded to lysine, a naturally occurring amino acid. This combined molecule is pharmacologically inert until red blood cell enzymes cleave lysine away, releasing free dextroamphetamine into the bloodstream.

Because this conversion can only happen after oral ingestion and absorption, attempting to abuse Vyvanse by non-oral routes does not produce the rapid peak effect that drives misuse. The drug's pharmacokinetics are also more predictable: because the rate-limiting step is enzymatic conversion rather than immediate absorption, the rise and fall of dextroamphetamine levels is smoother — contributing to what many patients describe as a less noticeable "wearing off."

Vyvanse's approval for binge eating disorder (BED) in adults is unique — no other amphetamine-class medication holds this indication. The mechanism in BED is not fully understood but is thought to involve dopamine pathways that modulate impulsive behavior and reward processing.

Prodrug limitation: Because conversion requires enzyme activity in red blood cells, the rate and extent of conversion can theoretically vary between individuals. Clinically, this variability is modest, but it is part of why prescribers individualize strength selection.

Shared across both medications

Side Effects

Adderall and Vyvanse share a nearly identical side effect profile because both ultimately produce dextroamphetamine. The differences lie mainly in severity and timing of comedown effects.

Appetite Suppression

One of the most consistent effects of both medications. Reduced appetite is expected and typically most pronounced during the period of peak drug activity. Weight loss can occur with sustained use, which is clinically significant in children and adolescents.

Insomnia

Both medications can make it difficult to fall or stay asleep, particularly if taken later in the day. Vyvanse's longer duration makes timing especially important. Sleep disruption is among the most common reasons prescribers adjust timing or reconsider the medication.

Elevated Heart Rate & Blood Pressure

Amphetamines stimulate the sympathetic nervous system. Modest increases in heart rate and blood pressure are expected. People with existing cardiovascular conditions require careful evaluation before starting either medication.

Dry Mouth

Common with both medications due to reduced saliva production. Staying hydrated helps. Persistent dry mouth can contribute to dental problems over time — something to discuss with both your prescriber and dentist.

Irritability / Mood Changes

Some people experience anxiety, irritability, or emotional lability, particularly as the medication wears off. Adderall IR's sharper offset can produce this more acutely. Vyvanse's gradual offset tends to reduce the severity of mood-related rebound effects.

Rebound / Comedown

As amphetamine levels fall, some people experience a "rebound" — a temporary worsening of ADHD symptoms, fatigue, or mood dip. This is more pronounced with Adderall IR due to its sharp pharmacokinetic curve. Adderall XR and Vyvanse both smooth this by design, though Vyvanse's longer-acting prodrug mechanism is generally considered the smoothest offset.

Black box warning: Both medications carry FDA black box warnings regarding potential for abuse, dependence, and serious cardiovascular events. Both also share warnings about psychiatric effects in individuals with underlying psychiatric conditions. Full prescribing information should be reviewed with your prescriber and pharmacist.

Clinical use cases

Which Is Better — For What?

Neither drug is universally superior. The right choice depends on individual factors including abuse history, insurance coverage, treatment goals, and how a person tolerates each drug's profile.

If abuse concern is a priority

Minimizing misuse potential

Vyvanse

The prodrug mechanism provides a structural barrier to non-oral misuse. Prescribers often prefer Vyvanse when abuse history or diversion risk is a clinical concern.

If cost is a priority

Lower out-of-pocket cost

Adderall generic

Generic Adderall (IR and XR) has been available for years and is typically far cheaper than even generic Vyvanse. For uninsured or underinsured patients, this difference can be substantial.

If the indication is BED

Binge eating disorder

Vyvanse only

Vyvanse is the only FDA-approved medication for moderate-to-severe binge eating disorder in adults. Adderall has no approved indication for this condition.

If longer coverage is needed

All-day coverage without redosing

Vyvanse

Vyvanse's 10–14 hour profile typically outlasts Adderall XR's 8–10 hours. For people who need consistent coverage through evening hours, Vyvanse often requires no supplemental dose.

If flexible timing is important

Targeted, time-limited coverage

Adderall IR

Adderall IR's shorter action window (~4–6 hours) allows some patients to take it only when needed and avoid effects during evenings or weekends. This flexibility is not possible with long-acting formulations.

If ADHD onset age is under 6

Younger children with ADHD

Adderall

Adderall is FDA-approved for ADHD starting at age 3. Vyvanse is approved starting at age 6. Prescribers treating younger children with stimulants will typically reach for Adderall or alternatives with pediatric approval.

Frequently asked questions

Common Questions

Is Adderall or Vyvanse stronger?

Neither is categorically stronger. Adderall contains both dextroamphetamine and levoamphetamine salts (roughly 75/25 ratio), while Vyvanse is converted entirely to dextroamphetamine in the body. Because Vyvanse's conversion is gradual, the two can produce therapeutically similar effects at appropriately selected strengths. The subjective sense of "strength" also depends on how quickly a drug peaks in the bloodstream — Adderall IR may feel more intense initially due to its faster onset, but this is a pharmacokinetic property, not an indicator of greater clinical potency. Your prescriber determines the appropriate strength based on your response and tolerability, not on a conversion formula.

Why is Vyvanse harder to abuse than Adderall?

Vyvanse (lisdexamfetamine) is a prodrug — it is pharmacologically inactive until enzymes in red blood cells cleave the lysine molecule away, releasing dextroamphetamine. This conversion happens only after oral ingestion and absorption into the bloodstream. If Vyvanse is crushed and snorted or dissolved for injection, the lisdexamfetamine molecule remains intact and inactive — there is no rapid delivery of active amphetamine. Adderall's amphetamine salts are immediately active, meaning non-oral routes of administration can produce a faster, more intense reinforcing effect. This prodrug design is the specific mechanism behind Vyvanse's lower abuse potential. It is worth noting, however, that Vyvanse remains a Schedule II controlled substance — it is not abuse-proof, and oral misuse (taking more than prescribed) is still possible and dangerous.

Can you switch from Adderall to Vyvanse?

Yes — switching between Adderall and Vyvanse is a common clinical decision and generally straightforward, but it must be done under prescriber supervision. Because Vyvanse is a prodrug with a different onset and duration profile, a direct switch (stopping one and starting the other) is typically how it is done — a gradual taper is not usually necessary when moving from one amphetamine formulation to another under medical guidance. Your prescriber will select an appropriate Vyvanse strength based on your current response to Adderall, your overall clinical history, and other factors. Do not attempt to estimate or convert strengths yourself — these medications are not equivalent on a milligram-for-milligram basis.

Which lasts longer, Adderall XR or Vyvanse?

Vyvanse generally lasts longer. Adderall XR is designed to last approximately 8–10 hours, achieved through a biphasic bead system that releases amphetamine in two waves. Vyvanse typically lasts 10–14 hours because its duration is governed by the rate of enzymatic conversion — a process that unfolds slowly and continuously after ingestion, creating a more sustained release of dextroamphetamine. Individual variation in metabolism, body composition, food intake, and other factors affects actual duration for both drugs. Some patients find Vyvanse persists into the evening to a degree that interferes with sleep, and timing becomes an important part of the clinical discussion.

Is Vyvanse better for binge eating disorder?

Vyvanse is the only FDA-approved medication for moderate-to-severe binge eating disorder (BED) in adults — so by regulatory definition, it is the indicated choice for this condition. Adderall has no approved indication for BED, and while some prescribers use it off-label in various contexts, it would not be a first-line or evidence-backed choice for BED specifically. The mechanism by which Vyvanse reduces binge eating episodes is not fully established, but is thought to involve dopamine-mediated impulse control pathways. As with all treatments for BED, medication is typically combined with psychological treatment approaches. Your prescriber will weigh your full medical history — including cardiovascular health, substance use history, and other medications — before recommending any stimulant for this indication.

Medical disclaimer

Important notice

This page is for informational and educational purposes only. It does not constitute medical advice, a prescription recommendation, or a substitute for professional clinical judgment. Adderall and Vyvanse are Schedule II controlled substances available by prescription only. All decisions about starting, stopping, switching, or adjusting these medications must be made by a qualified prescriber who has evaluated your full medical history, current medications, and individual circumstances. If you are in a medical emergency, call 911. For questions about your prescriptions, contact your prescriber or pharmacist. Poison Control: 1-800-222-1222.

Related Guides